Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Welgene Biotech

2003 FOUNDED
PUBLIC STATUS
71-80 EMPLOYEES
6661 STOCK SYMBOL
$0.67 SHARE PRICE (As of Friday Closing)
Description

Provider of laboratory services. The company's business includes stable gene-related research technology and is dedicated to applying the results of scientific research to clinical tests.

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Laboratory Services (Healthcare)
Stock Exchange
ROCO
Primary Office
  • Nangang District 3
  • Park Street 12th Floor
  • Taipei, 115-03
  • Taiwan

+886 00000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Welgene Biotech’s full profile, request a free trial.

Welgene Biotech Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.61 - $0.92 $14.4M $0.69 $0.03 29.2K 20.7M

Welgene Biotech Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2014
31-Dec-2014
Enterprise Value 11,086 11,486
Revenue 11,656 10,686 8,589 8,911
EBITDA 1,037 1,204 452 1,161
Net Income 576 776 126 696
Total Assets 9,768 10,511 8,502 7,018
Total Debt 904 1,045 727 1,514
Public Fundamental Data provided by Morningstar, Inc. disclaimer